MARKET INSIGHTS
(R)-Ethylnipecotate-L-Tartaric Acid (CAS 167392-57-6) Market – View in Detailed Research Report
Global (R)-Ethylnipecotate-L-Tartaric Acid (CAS 167392-57-6) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.5% during the forecast period.
(R)-Ethylnipecotate-L-Tartaric Acid (CAS 167392-57-6) is a chiral salt compound derived from (R)-ethyl nipecotate and L-tartaric acid, widely utilized as a key pharmaceutical intermediate in the synthesis of enantiomerically pure active pharmaceutical ingredients (APIs). Its well-defined stereochemical configuration makes it particularly valuable in the production of central nervous system (CNS) drugs, where precise chirality directly influences therapeutic efficacy and safety profiles.
The market is steadily gaining traction, driven by the growing emphasis on chiral chemistry and the increasing demand for stereochemically defined intermediates in drug development. The expanding pharmaceutical pipeline for CNS disorders – including anxiety, depression, and epilepsy – continues to underpin robust demand for high-purity chiral building blocks such as this compound. Furthermore, rising investment in asymmetric synthesis technologies and tightening regulatory requirements around racemic mixtures are compelling manufacturers to adopt enantioselective routes, directly benefiting the consumption of resolved chiral salts like (R)-Ethylnipecotate-L-Tartaric Acid.
10️⃣ 1. Capot Chemical Co., Ltd.
Headquarters: Shanghai, China
Key Offering: Bulk (R)-Ethylnipecotate-L-Tartaric Acid, high-purity API intermediates
Capot Chemical Co., Ltd. is a leading producer of chiral resolving agents, specializing in large‑scale synthesis of (R)-Ethylnipecotate-L-Tartaric Acid for CNS drug development. Their state‑of‑the‑art resolution process achieves >99% enantiomeric excess, supporting high‑value API production.
Sustainability Initiatives:
- Implementation of green solvent recycling
- Energy‑efficient continuous flow reactors
- ISO 14001 environmental certification
- Global supply chain partnerships
- Custom synthesis for pharma clients
- Investment in biocatalytic resolution
9️⃣ 2. Hairui Fine Chemicals Co., Ltd.
Headquarters: Guangzhou, China
Key Offering: High‑purity (R)-Ethylnipecotate-L-Tartaric Acid, specialty chiral intermediates
Hairui Fine Chemicals delivers premium chiral salts with strict impurity control, catering to advanced pharmaceutical manufacturers. Their production facilities are GMP‑certified, ensuring compliance with FDA and EMA standards.
Sustainability Initiatives:
- Zero‑waste solvent recovery
- Renewable energy usage
- Carbon footprint reduction targets
- Rapid turnaround for custom orders
- Strategic alliances with CROs
- Continuous improvement of resolution efficiency
8️⃣ 3. Finetech Industry Limited
Headquarters: Shenzhen, China
Key Offering: Bulk chiral salts, API intermediates
Finetech Industry specializes in scalable synthesis of (R)-Ethylnipecotate-L-Tartaric Acid, supporting high‑volume API production for CNS therapeutics.
Sustainability Initiatives:
- Water recycling systems
- Low‑energy continuous processes
- Green chemistry compliance
- High purity (>99.5%) product lines
- Robust quality assurance
- Global distribution network
7️⃣ 4. Matrix Scientific
Headquarters: San Diego, USA
Key Offering: Custom chiral synthesis, analytical services
Matrix Scientific offers bespoke synthesis of (R)-Ethylnipecotate-L-Tartaric Acid and advanced analytical support for pharma R&D, enabling rapid development of chiral APIs.
Sustainability Initiatives:
- Green solvent selection
- Process optimization for waste reduction
- Life‑cycle assessment integration
- GMP‑certified facilities
- Rapid prototyping capabilities
- Collaboration with pharma innovators
6️⃣ 5. Combi-Blocks Inc.
Headquarters: Boston, USA
Key Offering: Chiral building blocks, specialty chemicals
Combi-Blocks Inc. supplies high‑purity chiral intermediates, including (R)-Ethylnipecotate-L-Tartaric Acid, to pharmaceutical and academic researchers, supporting diverse synthetic routes.
Sustainability Initiatives:
- Eco‑friendly synthesis protocols
- Waste minimization programs
- Energy‑efficient manufacturing
- Extensive product catalog
- Technical support services
- Fast shipping and logistics
5️⃣ 6. Biosynth AG
Headquarters: Basel, Switzerland
Key Offering: Advanced chiral synthesis, API intermediates
Biosynth AG leads in asymmetric synthesis of (R)-Ethylnipecotate-L-Tartaric Acid, providing high‑quality chiral salts for pharmaceutical manufacturers and research institutions.
Sustainability Initiatives:
- Green chemistry research
- Carbon‑neutral production goals
- Regulatory compliance excellence
- GMP and ISO certifications
- Collaborations with pharma R&D
- Continuous innovation pipeline
4️⃣ 7. Enamine Ltd.
Headquarters: Kyiv, Ukraine
Key Offering: Chiral building blocks, custom synthesis
Enamine Ltd. offers a broad portfolio of chiral compounds, including (R)-Ethylnipecotate-L-Tartaric Acid, with a focus on flexibility and rapid turnaround for research and development.
Sustainability Initiatives:
- Biocatalytic resolution methods
- Low‑waste synthetic routes
- Energy‑efficient operations
- Global distribution
- Strong technical support
- Rapid custom synthesis
3️⃣ 8. Apollo Scientific Ltd.
Headquarters: London, UK
Key Offering: Chiral intermediates, analytical services
Apollo Scientific provides high‑purity (R)-Ethylnipecotate-L-Tartaric Acid and analytical solutions for pharma R&D, emphasizing quality and regulatory compliance.
Sustainability Initiatives:
- Green solvent usage
- Process waste reduction
- ISO 14001 certification
- GMP‑certified facilities
- Custom synthesis options
- Technical partnership programs
2️⃣ 9. Pharmaffiliates Analytics & Synthetics
Headquarters: Hyderabad, India
Key Offering: Custom chiral synthesis, analytical support
Pharmaffiliates Analytics & Synthetics specializes in tailored synthesis of (R)-Ethylnipecotate-L-Tartaric Acid for Indian and global pharma markets, offering rapid delivery and high quality.
Sustainability Initiatives:
- Eco‑friendly production
- Energy efficiency
- Waste reduction
- Custom order fulfillment
- Quality assurance
- Strategic partnerships
1️⃣ 10. Achemblocks Inc.
Headquarters: Bangalore, India
Key Offering: Bulk chiral salts, API intermediates
Achemblocks Inc. delivers high‑purity (R)-Ethylnipecotate-L-Tartaric Acid at competitive pricing, supporting large‑scale API production for CNS therapeutics.
Sustainability Initiatives:
- Green chemistry adoption
- Carbon footprint reduction
- Efficient resource utilization
- High‑volume production
- Quality compliance
- Global supply chain
Download FREE Sample Report: View Sample Report
Get Full Report Here: (R)-Ethylnipecotate-L-Tartaric Acid (CAS 167392-57-6) Market – View in Detailed Research Report
🌍 Outlook: The Future of (R)-Ethylnipecotate-L-Tartaric Acid Market Is Powered by Chiral Innovation
The (R)-Ethylnipecotate-L-Tartaric Acid market is poised for sustained growth, driven by expanding CNS drug pipelines, regulatory emphasis on enantioselectivity, and the shift toward greener resolution technologies. Manufacturers are investing in continuous flow reactors and biocatalytic processes to enhance yield, reduce waste, and lower production costs.
📈 Key Trends Shaping the Market:
- Rapid adoption of asymmetric synthesis technologies
- Increasing demand for high‑purity chiral intermediates in CNS therapeutics
- Regulatory push for non‑racemic drug candidates
- Growth of green chemistry and biocatalytic resolutions
- Strategic collaborations between API intermediates suppliers and pharma developers
- Top 10 Companies in the Silicone Feel Modifier Market (2026): Market Leaders Driving Global Innovation - June 24, 2026
- Top 10 Companies in the 1-(4-nitrophenyl)-2-thiourea Market (2026): Market Leaders Driving Global Specialty Chemical Growth - June 24, 2026
- Top 10 Companies in the Roll Roofing Market (2026): Market Leaders Powering Global Roofing - June 24, 2026